About this author

Malgorzata Kluba, PhD

Senior Biotechnology Analyst

Malgorzata Kluba has been a Senior Biotechnology Analyst at Candriam since 2019.

Before joining Candriam Malgorzata spent four years as an R&D scientist at ActoBio Therapeutics (Intrexon Actobiotics) in Belgium – a synthetic biology company where she had been working on novel drug delivery platform. She has also worked as a journalist for a life sciences communication agency (BioVox / Tunstone Communications), focusing on Belgian biotechnology market.

Malgorzata holds PhD degree in biochemistry and biotechnology from University of Leuven, Belgium, where she researched cancer signalling pathways.

Discover the latest articles by Malgorzata Kluba

Malgorzata Kluba, Rudi Van Den Eynde, Oncology, Renta variable

Día Mundial del Cáncer 2023

Y preferiríamos no tener que celebrarlo, lo que significaría que hemos ganado la batalla y que el cáncer es curable.
Cargando...

Buscador rápido

Obtenga información más rápidamente con un solo clic

Reciba información directamente en su bandeja de entrada